A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis
After at least one year of therapy the risk of PML was found to be 2.4 in 10,000.
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
- Family Elder
- Posts: 540
- Joined: Wed Jan 03, 2007 3:00 pm
- Location: Germany
Return to Tysabri (Antegren or Natalizumab)
Who is online
Users browsing this forum: No registered users